Tenkasi is an antibiotic used in adults and children from 3 months of age to treat acute (short-term) bacterial infections of the skin and of skin structures (tissue below the skin) such as cellulitis (inflammation of the deep skin tissue), skin abscesses and wound infections. It contains the active substance oritavancin.
Therapeutic Indication
### Therapeutic indication Tenkasi is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults and paediatric patients aged 3 months and older (see sections 4.2, 4.4 and 5.1). Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Therapeutic Area (MeSH)
ATC Code
J01XA05
ATC Item
oritavancin
Pharmacotherapeutic Group
Antibacterials for systemic use
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| oritavancin (diphosphate) | N/A | oritavancin (diphosphate) |
EMA Name
Tenkasi (previously Orbactiv)
Medicine Name
Tenkasi (previously Orbactiv)
Aliases
N/ANo risk management plan link.
